SIRT2 and head and neck cancer: In terms of the relationship between SIRT2 and other HIFs, Hu et al. reported that SIRT2 reduced the expression of VEGFD and lymphangiogenesis in hypoxia-induced head and neck cancer cells via deacetylation of HIF-2α and decreased transcriptional activity of HIF-2α-target genes [26].